#USA #Las Vegas #Medication Intelligence #First Databank #HIMSS 2026

FDB Showcases Cutting-Edge Medication Intelligence at HIMSS 2026

At the upcoming HIMSS 2026 Global Health Conference, FDB (First Databank) is set to unveil its latest advancements in medication intelligence. Focusing on the theme "Intelligence to Free Your Mind," the company aims to enhance the clinical workflows of healthcare professionals significantly. The event will take place at the Venetian Convention and Expo Center in Las Vegas, where FDB will demonstrate how its sophisticated medication intelligence solutions reduce cognitive load and streamline processes in healthcare settings.

Harnessing the Power of Medication Intelligence

With a reputation as a leading provider of drug knowledge, FDB understands that modern healthcare demands more than just access to medication data. According to Virginia Halsey, FDB's Vice President of Strategy and Product Management, the complexities of today's healthcare environment require advanced medication intelligence that integrates seamlessly with clinical workflows. FDB’s solutions are designed to ensure clarity and confidence in medication decisions, all while being tailored to the specific needs of patients.

A core component of FDB's offerings, the FDB MedProof Model Context Protocol (MCP), represents a transformative leap in how healthcare technology teams can connect their systems to trusted drug knowledge. By standardizing how medication intelligence is accessed and utilized, FDB's infrastructure supports scalability while maintaining accuracy.

Experience at HIMSS 26

Attendees of HIMSS 2026 will have the opportunity to visit FDB at booth #3235 and experience firsthand how medication intelligence fosters a more efficient work environment. Demonstrations will showcase how these intelligent solutions can be applied across various functions like prescribing, pharmacy verification, and patient education. By alleviating unnecessary steps and minimizing distractions, clinicians will be able to focus on delivering high-quality care.

In addition to MedKnowledge®, which serves as the backbone of FDB's medication intelligence, the company will feature FDB AlertSpace® 2.0. This upgraded alerting system is designed to combat alert fatigue among clinicians by reducing irrelevant notifications, allowing healthcare professionals to devote more attention to patient care. Moreover, FDB PatientFirst™ solutions will illustrate how patient-specific alerts enhance clinical decision-making, ensuring a more personalized approach to care.

Innovations in Workflow Automation

As healthcare organizations strive to enhance their operations through automation, FDB will unveil its innovative products designed for improving medication workflows. For instance, the FDB Script Agent™ utilizes AI to automate prescription entries directly into electronic health records (EHR), streamlining the process following patient visits. This innovation allows clinicians to spend less time on clerical tasks and more time focusing on patient care.

Additionally, the upcoming FDB VerifyAssist™ addresses the time-consuming task of medication order verification. By providing pharmacists with drug-specific criteria based on current clinical data, the tool minimizes the time spent on manual verifications, thus increasing workflow efficiency.

A Culture of Calm

Furthermore, FDB's commitment to creating a positive environment at HIMSS 26 will be evident through interactive experiences at its booth. Attendees can indulge in complimentary foot and shoulder massages, infused water, and refreshments during the busy conference schedule. Additionally, the session titled "Calm Continues at Happy Hour" will promote networking and relaxation among attendees.

To entice visitors, FDB will offer unique giveaways like "Chill Pill" pins, Zen-inspired adult coloring books, and the chance to win a Theragun Mini 3rd Gen massage device by participating in a raffle.

Conclusion

With a robust lineup of innovative solutions and a focus on simplifying medication workflows, FDB is poised to make a significant impact at HIMSS 2026. The insights gained during this event will not only enhance clinician experiences but ultimately improve patient outcomes across the healthcare spectrum.

For more information about FDB and its groundbreaking medication intelligence solutions, feel free to visit FDB’s dedicated conference webpage or their booth at HIMSS 2026.